Company intelligence / Profile preview

New Jersey Cancer Care

Roselle, NJ, USA

Ownership: Private
Development stage: Other

Overview

Provides comprehensive cancer care and blood disorder management at four active New Jersey locations. Offers chemotherapy, hematology services, clinical research participation, infusion therapy, and supportive services.

Therapeutic areas: HematologyOncology
Modalities: Chemotherapy (Small molecule, Biologic)Infusion therapy (Biologic, Small molecule)
Industry: Non-Academic Healthcare

Partnerships

Member of Quality Cancer Care Alliance (QCCA), a national organization focused on cancer care quality improvement

Beyond the preview

Go deeper on New Jersey Cancer Care.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on New Jersey Cancer Care.

Explore the full profile